Pages
Team
Publications
Resources
- Converting Liver Tumors into Low-Oxygen Environment to Activate Drug to Drive Cell Death with Dr. Ray Lee Teclison
- Triggering a Systemic Immune Response Against Cancer
- World Cancer Research Day Highlights Innovation in Immuno-Oncology
- PharmaShots Interview: Teclison’s Ray Lee Shares Insights on the $5.9 Million Capital Raise
- Teclison raises $5.9M to advance solid tumor program
- Teclison Closes $5.9M Funding Round
- Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma
- Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination